Cargando…
The 1027(th) target candidate in stroke: Will NADPH oxidase hold up?
As recently reviewed, 1026 neuroprotective drug candidates in stroke research have all failed on their road towards validation and clinical translation, reasons being quality issues in preclinical research and publication bias. Quality control guidelines for preclinical stroke studies have now been...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403875/ https://www.ncbi.nlm.nih.gov/pubmed/22625431 http://dx.doi.org/10.1186/2040-7378-4-11 |